This educational program will aim to discuss cannabidiol use for medical disorders, specifically epilepsy. The content will compare cannabidiol from other cannabis-related products, illustrate the mechanisms of action of cannabidiol for epilepsy, and review current clinical data in this area, and discuss the importance of shared decision making in clinical practice, including education on the efficacy and safety profiles of cannabidiol to address misconceptions with patients and caregivers.

RELEASED DATE: October 17, 2024
EXPIRATION DATE: October 17, 2025

This educational program will discuss the burden of idiopathic hypersomnia (IH), assess mechanisms that address underlying pathology of the disease, and analyze available clinical data that look at the effect of treatment on sleep habits, quality of life, and cardiovascular risk. The program will also use guidelines and cases to describe best practices in patient counseling to ensure effective use of approved therapy for IH.

RELEASED DATE: October 18, 2024
EXPIRATION DATE: October 18, 2025

In this enduring activity, we will provide learners with an overview of idiopathic hypersomnia, focusing on early identification and diagnosis, and both nonpharmacologic and pharmacologic treatment options. We will help improve clinicians’ ability to distinguish between IH and other sleep disorders, interpret the latest efficacy and safety data for approved and off-label treatments, and understand the increased cardiovascular risk linked to IH and other sleep disorders.

RELEASED DATE: November 04, 2024
EXPIRATION DATE: November 04, 2025

This educational activity is designed to help learners better understand the history of developmental and epileptic encephalopathies (DEEs), utilize genetic evaluation for patients with DEEs, and review best practices for managing the comprehensive burdens of DEEs.

RELEASED DATE: October 31, 2024
EXPIRATION DATE: November 27, 2025

Welcome to an enlightening enduring activity dedicated to elevating the knowledge and skill set of cardiologists in managing patients with idiopathic hypersomnia (IH) and narcolepsy. As vital members of the multidisciplinary team (MDT), cardiologists play a crucial role in addressing the unique challenges presented by these sleep disorders. This symposium specifically aims to enrich your understanding of the cardiovascular risks associated with IH and narcolepsy, empowering you to implement evidence-based treatment strategies that prioritize patient safety and well-being.

The education will seek to help HCPs better assess the burden of IH and narcolepsy, including the major cardiovascular risks comorbid with IH and narcolepsy; summarize the importance of limiting sodium intake to manage cardiovascular risk in patients with IH and narcolepsy, including through use of lower-sodium oxybate; and justify the importance of a multidisciplinary shared decision-making approach in patients with IH and narcolepsy to ensure optimal clinical management.

RELEASED DATE: December 03, 2024
EXPIRATION DATE: December 03, 2025

This unique educational program is designed to increase the target audience’s ability to provide a timely and accurate DEE diagnosis, utilize evidence-based, multidisciplinary best practices for disease management, and empower patients with DEEs and their caregivers to actively participate in the treatment journey which will improve the pediatric-to-adult transition of care and long-term outcomes.

RELEASED DATE: December 06, 2024
EXPIRATION DATE: December 06, 2025